Skip to content

Gross Profit at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$117.25M+20.5%
Viatris logo
ViatrisVTRS
$1.16B-0.3%
PTH
Pelthos Therapeutics Inc.PTHS
$9.23M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$54.21M+10.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$34.32M+80.1%
Opko Health logo
Opko HealthOPK
$45.76M+7.4%

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.4%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Calculated from Scilex Holding Company’s reported figures.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's gross profit?
Scilex Holding Company (SCLX) reported gross profit of $4.17M in Q1 2026.
How has Scilex Holding Company's gross profit changed year-over-year?
Scilex Holding Company's gross profit increased by 15.1% year-over-year, from $3.62M to $4.17M.
What is the long-term trend for Scilex Holding Company's gross profit?
Over 4 years (2021 to 2025), Scilex Holding Company's gross profit has grown at a -8.2% compound annual growth rate (CAGR), from $27.68M to $19.65M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.